Cardiogenic shock complicates successful treatment of refractory thrombotic thrombocytopenia purpura with rituximab.
about
Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpuraAnti-CD20 antibody in thrombotic thrombocytopenic purpura refractory to plasma exchange.Rituximab in the treatment of autoimmune haematological disorders.Rituximab for managing relapsing or refractory patients with idiopathic thrombotic thrombocytopenic purpura--haemolytic uraemic syndromeCase series: splenectomy: does it still play a role in the management of thrombotic thrombocytopenic purpura?Efficacy of rituximab in acute refractory or chronic relapsing non-familial idiopathic thrombotic thrombocytopenic purpura: a systematic review with pooled data analysis.Relapses of thrombotic thrombocytopenic purpura after treatment with rituximab.How we approach an acquired thrombotic thrombocytopenic purpura patient.Non-ischemic cardiomyopathy after rituximab treatment for membranous nephropathy.Severe left ventricular systolic dysfunction in a patient with a typical haemolytic-uraemic syndrome treated with rituximab-coincidence or cause?Efficacy and Safety of Rituximab for Refractory and Relapsing Thrombotic Thrombocytopenic Purpura: A Cohort of 10 Cases.Clinical review: Serious adverse events associated with the use of rituximab - a critical care perspective.Biologic drugs and arrhythmic risk in chronic inflammatory arthritis: the good and the bad.Rituximab and cytokine release syndrome.Anterior ST-elevation myocardial infarction induced by rituximab infusion: A case report and review of the literature.Posttransplant Lymphoproliferative Disorder after Cardiac Transplantation in Children: Life Threatening Complications Associated with Chemotherapy Combined with Rituximab
P2860
Q24651320-A0E683A8-5936-4D0E-BDFE-BC8D2689EC69Q33375264-1F37D176-151F-4C91-9448-AF092C59F6CCQ33378854-FF77A55A-DFAB-4725-94A2-06796AD64D32Q33391086-C2340DBA-D6B5-49E7-9537-9AE8D2707B1AQ33391962-106FE6F0-BEAE-4626-94C1-01F98965B995Q33401010-3B2D6F9B-5D02-4A78-B092-D3F0B09F1C98Q33409112-1E7606D9-DFC0-4613-9AA9-E50634135D2FQ33416780-D8D4355A-D76F-467B-92F4-6BC064A7A8EFQ33630988-8A96E8BF-22C3-41D7-AA81-9438FDE80241Q33816958-91B8BCE7-4CDD-4809-8485-86DBD233B4B1Q35672416-B890CA7C-57AF-4B01-B208-3C7ACB7B7E2EQ36633769-4F3E0338-0493-4731-9801-BD4E162BD243Q38898838-0322E382-FBD7-4D22-BA8D-AF46BAA3E801Q41859216-5CF7804C-406D-455A-8DA7-F1D5484E8395Q51036612-4ABAEE78-BBD7-43AF-8A3A-3ED2BBF8532FQ58998353-A96D513B-573E-48F2-A29C-18D4A062733B
P2860
Cardiogenic shock complicates successful treatment of refractory thrombotic thrombocytopenia purpura with rituximab.
description
2005 nî lūn-bûn
@nan
2005 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Cardiogenic shock complicates ...... openia purpura with rituximab.
@ast
Cardiogenic shock complicates ...... openia purpura with rituximab.
@en
type
label
Cardiogenic shock complicates ...... openia purpura with rituximab.
@ast
Cardiogenic shock complicates ...... openia purpura with rituximab.
@en
prefLabel
Cardiogenic shock complicates ...... openia purpura with rituximab.
@ast
Cardiogenic shock complicates ...... openia purpura with rituximab.
@en
P2093
P2860
P1433
P1476
Cardiogenic shock complicates ...... openia purpura with rituximab.
@en
P2093
Afenyi-Annan A
Bandarenko N
Brecher ME
Millward PM
P2860
P304
P356
10.1111/J.1537-2995.2005.00560.X
P577
2005-09-01T00:00:00Z